Regulatory View
Drug Approvals Timeline
Browse approved drugs from the ChEMBL database with approval year, target, indication, and project-aligned signal context.
Window
2006 - 2026
approval filter range
Approvals
200
records returned
Signals
0
project-matched cues
Project Context
포트폴리오 보기
Browse the full approvals landscape, then return to search to narrow the context.
Approvals by Year
Timeline density across the current filter window.
Refine the timeline
Approval records
Total: 200 approvals
| Compound | Year | Indication | Target |
|---|---|---|---|
|
LAZERTINIB
CHEMBL4558324
|
2024 | — |
Epidermal growth factor receptor
CHEMBL203
|
|
POLIHEXANIDE
CHEMBL2106939
|
2024 | Acanthamoeba Keratitis, Eye Infections |
Cell membrane
CHEMBL2364031
|
|
OLEZARSEN SODIUM
CHEMBL4650263
|
2024 | — | |
|
CEFTOBIPROLE MEDOCARIL SODIUM
CHEMBL4297101
|
2024 | Adenocarcinoma, Bacteremia, Skin Diseases, Bacterial |
MecA
CHEMBL2362973
|
|
LANDIOLOL HYDROCHLORIDE
CHEMBL2362410
|
2024 | Atrial Fibrillation, Atrial Flutter, Tachycardia, Supraventricular |
Beta-1 adrenergic receptor
CHEMBL213
|
|
IOMEPROL
CHEMBL2107214
|
2024 | Diagnostic Imaging | |
|
ENMETAZOBACTAM
CHEMBL4458276
|
2024 | — |
Beta-lactamase TEM
CHEMBL2364670
|
|
VORASIDENIB
CHEMBL4279047
|
2024 | Astrocytoma, Oligodendroglioma |
IDH1/IDH2
CHEMBL4523659
|
|
SULOPENEM ETZADROXIL
CHEMBL4594246
|
2024 | — |
Bacterial penicillin-binding protein
CHEMBL2354204
|
|
DANICOPAN
CHEMBL4250860
|
2024 | Hemoglobinuria, Paroxysmal, Hemolysis |
Complement factor D
CHEMBL2176771
|
| 2024 | Respiratory Syncytial Virus Infections, Vaccination |
Fusion glycoprotein F0
CHEMBL2364165
|
|
|
ACORAMIDIS HYDROCHLORIDE
CHEMBL4650226
|
2024 | Amyloidosis, Cardiomyopathies |
Transthyretin
CHEMBL3194
|
|
REVUMENIB
CHEMBL4650827
|
2024 | — | |
|
INAVOLISIB
CHEMBL4650215
|
2024 | Breast Neoplasms |
Phosphatidylinositol...
CHEMBL4005
|
|
LAZERTINIB MESYLATE
CHEMBL6068478
|
2024 | Carcinoma, Non-Small-Cell Lung |
Epidermal growth factor receptor
CHEMBL203
|
|
ARIMOCLOMOL
CHEMBL2107726
|
2024 | — | |
|
BENZGALANTAMINE GLUCONATE
CHEMBL6068431
|
2024 | Dementia |
Acetylcholinesterase
CHEMBL220
|
|
FLURPIRIDAZ F 18
CHEMBL2107799
|
2024 | Myocardial Perfusion Imaging, Positron-Emission Tomography | |
|
GIVINOSTAT HYDROCHLORIDE
CHEMBL6068400
|
2024 | Muscular Dystrophy, Duchenne |
Histone deacetylase
CHEMBL2093865
|
|
REVUMENIB CITRATE
CHEMBL6068395
|
2024 | Leukemia |
Menin
CHEMBL1615381
|
|
XANOMELINE TARTRATE
CHEMBL2336050
|
2024 | — |
Muscarinic acetylcholine receptor M1
CHEMBL1821
|
|
ENSARTINIB
CHEMBL4113131
|
2024 | — |
ALK tyrosine kinase receptor
CHEMBL4247
|
|
FOSCARBIDOPA
CHEMBL4802240
|
2024 | — |
Aromatic-L-amino-acid decarboxylase
CHEMBL1843
|
|
CRINECERFONT
CHEMBL291657
|
2024 | Adrenal Hyperplasia, Congenital |
Corticotropin-releasing factor receptor 1
CHEMBL1800
|
|
LIFILEUCEL
CHEMBL4298200
|
2024 | Melanoma | |
|
SELADELPAR
CHEMBL230158
|
2024 | — |
Peroxisome proliferator-activated...
CHEMBL3979
|
|
MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE
CHEMBL6068336
|
2024 | Myeloproliferative Disorders, Splenomegaly |
Activin receptor type-1
CHEMBL2835
|
|
INSULIN ICODEC
CHEMBL4594581
|
2024 | Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 |
Insulin receptor
CHEMBL1981
|
|
AFAMITRESGENE AUTOLEUCEL
CHEMBL4802254
|
2024 | Sarcoma, Synovial |
Melanoma-associated antigen 4
CHEMBL4296022
|
|
SUGEMALIMAB
CHEMBL4594535
|
2024 | Carcinoma, Non-Small-Cell Lung, Neoplasms |
Programmed cell death 1 ligand 1
CHEMBL3580522
|
|
PEMETREXED DIPOTASSIUM
CHEMBL6068329
|
2024 | Carcinoma, Non-Small-Cell Lung |
Dihydrofolate reductase
CHEMBL202
|
|
LANDIOLOL
CHEMBL1742466
|
2024 | — |
Beta-1 adrenergic receptor
CHEMBL213
|
|
ACETYLCYSTEINE LYSINE
CHEMBL6068327
|
2024 | Chemical and Drug Induced Liver Injury | |
|
FIDANACOGENE ELAPARVOVEC
CHEMBL3990034
|
2024 | Hemophilia B, Hemorrhage, Primary Immunodeficiency Diseases |
Coagulation factor IX
CHEMBL2016
|
|
SELADELPAR LYSINE
CHEMBL3989960
|
2024 | Liver Cirrhosis, Biliary |
Peroxisome proliferator-activated...
CHEMBL3979
|
|
BERDAZIMER SODIUM
CHEMBL4298064
|
2024 | Molluscum Contagiosum | |
|
RESMETIROM
CHEMBL3261331
|
2024 | Non-alcoholic Fatty Liver Disease |
Thyroid hormone receptor beta
CHEMBL1947
|
|
FLURPIRIDAZ
CHEMBL494622
|
2024 | — | |
|
CEFTOBIPROLE MEDOCARIL FREE ACID
CHEMBL1652606
|
2024 | — | |
|
AMDINOCILLIN PIVOXIL
CHEMBL1650818
|
2024 | Bacterial Infections, Urinary Tract Infections |
Peptidoglycan D,D-transpeptidase MrdA
CHEMBL2354313
|
|
LEVACETYLLEUCINE
CHEMBL56021
|
2024 | Niemann-Pick Disease, Type C | |
|
TOVORAFENIB
CHEMBL3348923
|
2024 | Glioma |
RAF serine/threonine protein kinase
CHEMBL3559685
|
|
CONCIZUMAB
CHEMBL4297730
|
2024 | Hemorrhage |
Tissue factor pathway inhibitor
CHEMBL3713062
|
|
ENSIFENTRINE
CHEMBL4594287
|
2024 | Pulmonary Disease, Chronic Obstructive |
Phosphodiesterase 3
CHEMBL2093863
|
|
BENZGALANTAMINE
CHEMBL5095056
|
2024 | — | |
|
IMETELSTAT SODIUM
CHEMBL2108702
|
2024 | Anemia |
Telomerase reverse transcriptase
CHEMBL2916
|
|
ACORAMIDIS
CHEMBL3940890
|
2024 | — |
Transthyretin
CHEMBL3194
|
|
APROCITENTAN
CHEMBL2165326
|
2024 | Hypertension |
Endothelin receptor, ET-A/ET-B
CHEMBL2096678
|
|
OBECABTAGENE AUTOLEUCEL
CHEMBL5095440
|
2024 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
B-lymphocyte antigen CD19
CHEMBL3390821
|
|
XANOMELINE
CHEMBL21536
|
2024 | — |
Muscarinic acetylcholine receptor M1
CHEMBL1821
|
|
DEUTIVACAFTOR
CHEMBL4297603
|
2024 | — |
Cystic fibrosis transmembrane...
CHEMBL4051
|
|
DEURUXOLITINIB PHOSPHATE
CHEMBL4594382
|
2024 | Alopecia Areata |
Non-receptor tyrosine-protein kinase TYK2
CHEMBL2148
|
|
ARIMOCLOMOL CITRATE
CHEMBL4298149
|
2024 | Niemann-Pick Disease, Type C | |
|
FOSLEVODOPA
CHEMBL4594379
|
2024 | — |
Beta-1 adrenergic receptor
CHEMBL213
|
|
ELAFIBRANOR
CHEMBL3707395
|
2024 | Cholangitis |
Peroxisome proliferator-activated...
CHEMBL239
|
|
MAVORIXAFOR
CHEMBL518924
|
2024 | Neoplasms |
C-X-C chemokine receptor type 4
CHEMBL2107
|
|
PEGULICIANINE ACETATE
CHEMBL4594345
|
2024 | Optical Imaging, Ultrasonography | |
|
SOFPIRONIUM BROMIDE
CHEMBL3707223
|
2024 | Hyperhidrosis |
Muscarinic acetylcholine receptor
CHEMBL2094109
|
|
GIVINOSTAT
CHEMBL1213492
|
2024 | — | |
|
VANZACAFTOR
CHEMBL5314934
|
2024 | — |
Cystic fibrosis transmembrane...
CHEMBL4051
|
|
SOFPIRONIUM
CHEMBL3707224
|
2024 | — | |
|
BEVACIZUMAB GAMMA
CHEMBL5314727
|
2024 | Wet Macular Degeneration |
Vascular endothelial growth factor...
CHEMBL1783
|
|
MOMELOTINIB
CHEMBL1078178
|
2023 | — |
Tyrosine-protein kinase JAK1
CHEMBL2835
|
|
ZAVEGEPANT
CHEMBL2397415
|
2023 | — |
Calcitonin-gene-related peptide...
CHEMBL2107838
|
|
LOVOTIBEGLOGENE AUTOTEMCEL
CHEMBL4650269
|
2023 | Anemia, Sickle Cell |
Hemoglobin subunit beta
CHEMBL4331
|
|
HEPARIN
CHEMBL4650299
|
2023 | Eye Diseases, Thrombosis, Varicose Veins |
Antithrombin-III
CHEMBL1950
|
|
EPCORITAMAB
CHEMBL4650393
|
2023 | Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Neoplasms |
B-lymphocyte antigen CD20
CHEMBL2058
|
|
VAMOROLONE
CHEMBL2348780
|
2023 | Muscular Dystrophy, Duchenne |
Glucocorticoid receptor
CHEMBL1994
|
|
BEXAGLIFLOZIN
CHEMBL1808388
|
2023 | Diabetes Mellitus, Diabetes Mellitus, Type 2 |
Sodium/glucose cotransporter 2
CHEMBL3884
|
|
DELANDISTROGENE MOXEPARVOVEC
CHEMBL4650241
|
2023 | Muscular Dystrophy, Duchenne |
Dystrophin
CHEMBL5498504
|
|
EFBEMALENOGRASTIM ALFA
CHEMBL4297950
|
2023 | Chemotherapy-Induced Febrile Neutropenia, Neoplasms, Neutropenia |
Granulocyte colony-stimulating...
CHEMBL1996
|
|
AVACINCAPTAD PEGOL SODIUM
CHEMBL4297889
|
2023 | Geographic Atrophy |
Complement C5
CHEMBL2364163
|
|
PIRTOBRUTINIB
CHEMBL4650485
|
2023 | Lymphoma, Mantle-Cell, Neoplasms |
Tyrosine-protein kinase BTK
CHEMBL5251
|
|
ZAVEGEPANT HYDROCHLORIDE
CHEMBL4650220
|
2023 | Migraine Disorders |
Calcitonin gene-related peptide type...
CHEMBL3798
|
|
TORIPALIMAB
CHEMBL4297843
|
2023 | Nasopharyngeal Carcinoma, Neoplasms |
Programmed cell death protein 1
CHEMBL3307223
|
|
NIROGACESTAT
CHEMBL1770916
|
2023 | — |
Gamma-secretase
CHEMBL2094135
|
|
NIRMATRELVIR
CHEMBL4802135
|
2023 | — |
Replicase polyprotein 1a
CHEMBL3927
|
|
TISLELIZUMAB
CHEMBL4297840
|
2023 | Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Neoplasms, Stomach Neoplasms |
Programmed cell death protein 1
CHEMBL3307223
|
|
GEPIRONE
CHEMBL284092
|
2023 | — |
5-hydroxytryptamine receptor 1A
CHEMBL214
|
|
ROZANOLIXIZUMAB
CHEMBL4297820
|
2023 | Myasthenia Gravis |
IgG receptor FcRn large subunit p51
CHEMBL5966
|
|
APADAMTASE ALFA
CHEMBL4594607
|
2023 | Purpura, Thrombotic Thrombocytopenic |
A disintegrin and metalloproteinase...
CHEMBL2346492
|
|
TROFINETIDE
CHEMBL197084
|
2023 | Rett Syndrome | |
|
LEBRIKIZUMAB
CHEMBL1743035
|
2023 | Dermatitis, Atopic, Eczema |
Interleukin-13
CHEMBL3580486
|
|
CAPIVASERTIB
CHEMBL2325741
|
2023 | Breast Neoplasms, Neoplasms |
Serine/threonine-protein kinase AKT
CHEMBL2111353
|
|
RETIFANLIMAB
CHEMBL4298037
|
2023 | Carcinoma, Merkel Cell, Carcinoma, Squamous Cell, Neoplasms |
Programmed cell death protein 1
CHEMBL3307223
|
|
ELRANATAMAB
CHEMBL4297809
|
2023 | Multiple Myeloma, Neoplasms |
T cell surface glycoprotein CD3
CHEMBL2364168
|
|
PEGZILARGINASE
CHEMBL4297803
|
2023 | Hyperargininemia |
L-arginine
CHEMBL4651302
|
|
PEGUNIGALSIDASE ALFA
CHEMBL4297801
|
2023 | Fabry Disease |
Globotriosylceramide
CHEMBL2366040
|
|
CANTHARIDIN
CHEMBL48449
|
2023 | Molluscum Contagiosum | |
|
MOMELOTINIB DIHYDROCHLORIDE
CHEMBL2219411
|
2023 | Polycythemia Vera, Primary Myelofibrosis, Thrombocythemia, Essential | |
|
TALQUETAMAB
CHEMBL4594503
|
2023 | Multiple Myeloma, Neoplasms |
G-protein coupled receptor family C...
CHEMBL2364168
|
|
IPTACOPAN
CHEMBL4594448
|
2023 | — |
Complement factor B
CHEMBL5731
|
|
ETRASIMOD
CHEMBL3358920
|
2023 | — |
Sphingosine 1-phosphate receptor 1
CHEMBL4333
|
|
POZELIMAB
CHEMBL4298086
|
2023 | Protein-Losing Enteropathies |
Complement C5
CHEMBL2364163
|
|
GLOFITAMAB
CHEMBL4298092
|
2023 | Lymphoma, Large B-Cell, Diffuse, Neoplasms |
B-lymphocyte antigen CD20
CHEMBL2058
|
|
DAPRODUSTAT
CHEMBL3544988
|
2023 | Anemia, Renal Insufficiency, Chronic |
Hypoxia-inducible factor prolyl hydroxylase
CHEMBL3831261
|
|
EFANESOCTOCOG ALFA
CHEMBL5095275
|
2023 | Hemophilia A |
Coagulation factor VIII
CHEMBL3143
|
|
IPTACOPAN HYDROCHLORIDE
CHEMBL5095401
|
2023 | Glomerulonephritis, IGA, Hemoglobinuria, Paroxysmal |
Complement factor B
CHEMBL5731
|
|
MOTIXAFORTIDE ACETATE
CHEMBL5095449
|
2023 | Multiple Myeloma, Transplantation, Autologous | |
|
ETRANACOGENE DEZAPARVOVEC
CHEMBL5095451
|
2023 | Hemophilia B, Hemorrhage |
Coagulation factor IX
CHEMBL2016
|
|
EXAGAMGLOGENE AUTOTEMCEL
CHEMBL5095474
|
2023 | Anemia, Sickle Cell, beta-Thalassemia, Vaso-Occlusive Crises |
B-cell lymphoma/leukemia 11A
CHEMBL5498502
|
|
PALOPEGTERIPARATIDE
CHEMBL5095475
|
2023 | Hypoparathyroidism |
Parathyroid hormone/parathyroid...
CHEMBL1793
|
|
FEZOLINETANT
CHEMBL3608680
|
2023 | Hot Flashes |
Neuromedin-K receptor
CHEMBL4429
|
|
LENIOLISIB
CHEMBL3643413
|
2023 | — |
Phosphatidylinositol...
CHEMBL3130
|
|
VADADUSTAT
CHEMBL3646221
|
2023 | Anemia, Renal Insufficiency, Chronic |
Egl nine homolog 1
CHEMBL3028
|
|
NEDOSIRAN SODIUM
CHEMBL4594338
|
2023 | Hyperoxaluria, Primary |
L-lactate dehydrogenase A chain mRNA
CHEMBL4627242
|
|
EPLONTERSEN SODIUM
CHEMBL4594335
|
2023 | Amyloid Neuropathies, Familial, Polyneuropathies |
Transthyretin mRNA
CHEMBL4296221
|
|
FLOTUFOLASTAT F-18 GALLIUM
CHEMBL5314559
|
2023 | Diagnostic Imaging | |
|
PERFLUOROHEXYLOCTANE
CHEMBL5314588
|
2023 | Dry Eye Syndromes | |
|
GEPIRONE HYDROCHLORIDE
CHEMBL1204187
|
2023 | Depressive Disorder, Major |
5-hydroxytryptamine receptor 1A
CHEMBL214
|
|
SPARSENTAN
CHEMBL539423
|
2023 | Glomerulonephritis, IGA |
Endothelin-1 receptor
CHEMBL227
|
|
RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F
CHEMBL6068489
|
2023 | Respiratory Syncytial Virus Infections, Vaccination |
Fusion glycoprotein F0
CHEMBL2364165
|
|
OMAVELOXOLONE
CHEMBL4303525
|
2023 | Friedreich Ataxia |
Nuclear factor erythroid 2-related factor 2
CHEMBL1075094
|
|
FRUQUINTINIB
CHEMBL4303214
|
2023 | Colorectal Neoplasms, Neoplasms |
Vascular endothelial growth factor receptor
CHEMBL2095227
|
|
QUIZARTINIB DIHYDROCHLORIDE
CHEMBL2105709
|
2023 | Leukemia, Myeloid, Leukemia, Myeloid, Acute |
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
|
|
ELACESTRANT
CHEMBL4297509
|
2023 | — |
Estrogen receptor
CHEMBL206
|
|
COAGULATION FACTOR VII HUMAN
CHEMBL6068490
|
2023 | Coagulation Protein Disorders |
Coagulation factor VII
CHEMBL3991
|
|
ZURANOLONE
CHEMBL4105630
|
2023 | Depression, Postpartum, Depressive Disorder |
GABA-A receptor; anion channel
CHEMBL2093872
|
|
RITLECITINIB
CHEMBL4085457
|
2023 | — |
TEC family kinase
CHEMBL2148
|
|
PROTEIN S HUMAN
CHEMBL6068491
|
2023 | Coagulation Protein Disorders |
Vitamin K-dependent protein S
CHEMBL5498501
|
|
PROTHROMBIN
CHEMBL6068492
|
2023 | Blood Coagulation Disorders |
Prothrombin
CHEMBL204
|
|
BACILLUS ANTHRACIS PROTECTIVE ANTIGEN, ADSORBED
CHEMBL6068494
|
2023 | Anthrax |
Protective antigen
CHEMBL5352
|
|
OMIDUBICEL
CHEMBL4298190
|
2023 | Hematologic Neoplasms | |
|
ELTROMBOPAG CHOLINE
CHEMBL6068328
|
2023 | Anemia, Aplastic, Hepatitis C, Chronic, Purpura, Thrombocytopenic, Idiopathic, Thrombocytopenia |
Thrombopoietin receptor
CHEMBL1864
|
|
MIRIKIZUMAB
CHEMBL3990014
|
2023 | Colitis, Ulcerative, Crohn Disease, Immune System Diseases |
Interleukin-23
CHEMBL2364154
|
|
REZAFUNGIN
CHEMBL3989945
|
2023 | — | |
|
QUIZARTINIB
CHEMBL576982
|
2023 | — |
Macrophage colony-stimulating factor...
CHEMBL1844
|
|
ELACESTRANT HYDROCHLORIDE
CHEMBL4594273
|
2023 | Breast Neoplasms, Breast Neoplasms, Male |
Estrogen receptor
CHEMBL206
|
|
ETRASIMOD ARGININE
CHEMBL3989933
|
2023 | Colitis, Ulcerative |
Sphingosine 1-phosphate receptor 1
CHEMBL2274
|
|
REZAFUNGIN ACETATE
CHEMBL3989928
|
2023 | Candidemia, Candidiasis, Candidiasis, Invasive |
Candida
CHEMBL612867
|
|
PALOVAROTENE
CHEMBL2105648
|
2023 | Myositis Ossificans |
Retinoic acid receptor gamma
CHEMBL2003
|
|
LENIOLISIB PHOSPHATE
CHEMBL3989909
|
2023 | Primary Immunodeficiency Diseases |
Phosphatidylinositol...
CHEMBL3130
|
|
CHIKUNGUNYA VIRUS, LIVE ATTENUATED
CHEMBL6068495
|
2023 | Chikungunya Fever, Vaccination | |
|
GEFAPIXANT CITRATE
CHEMBL4594278
|
2023 | Chronic Cough, Cough |
P2X purinoceptor 3
CHEMBL2998
|
|
TAUROLIDINE
CHEMBL2105420
|
2023 | — |
Cell wall
CHEMBL5303716
|
|
FLOTUFOLASTAT GALLIUM
CHEMBL5316156
|
2023 | — | |
|
OMIDUBICEL NON-CULTURED FRACTION
CHEMBL6068497
|
2023 | Hematologic Neoplasms | |
|
FECAL MICROBIOTA SPORES, LIVE
CHEMBL6068500
|
2023 | Clostridium Infections | |
|
CRISANTASPASE
CHEMBL2108931
|
2023 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Asparagine
CHEMBL2364706
|
|
TOFERSEN
CHEMBL3833346
|
2023 | Amyotrophic Lateral Sclerosis |
SOD1 mRNA
CHEMBL3833461
|
|
DURLOBACTAM SODIUM
CHEMBL4297378
|
2023 | — |
Beta-lactamase
CHEMBL1075159
|
|
DONISLECEL
CHEMBL4594332
|
2023 | Hypoglycemia | |
|
RITLECITINIB TOSYLATE
CHEMBL5314649
|
2023 | Alopecia Areata |
TEC family kinase
CHEMBL2148
|
|
TECHNETIUM TC-99M LABELED CARBON
CHEMBL5314650
|
2023 | Diagnostic Imaging | |
|
SELVACOVATEIN
CHEMBL5314796
|
2023 | COVID-19, Vaccination |
Spike glycoprotein
CHEMBL4662936
|
|
ZILUCOPLAN SODIUM
CHEMBL5315048
|
2023 | Myasthenia Gravis |
Complement C5
CHEMBL2364163
|
|
CIPAGLUCOSIDASE ALFA
CHEMBL4594329
|
2023 | Glycogen Storage Disease Type II |
Glycogen
CHEMBL4662969
|
|
BEREMAGENE GEPERPAVEC
CHEMBL4594328
|
2023 | Epidermolysis Bullosa Dystrophica, Skin Ulcer, Wounds and Injuries |
Collagen alpha-1(VII) chain
CHEMBL5498505
|
|
DURLOBACTAM
CHEMBL4298137
|
2023 | — | |
|
REPOTRECTINIB
CHEMBL4298138
|
2023 | Neoplasms |
BDNF/NT-3 growth factors receptor
CHEMBL2815
|
|
GEFAPIXANT
CHEMBL3716057
|
2023 | — |
P2X purinoceptor 3
CHEMBL2998
|
|
NIROGACESTAT HYDROBROMIDE
CHEMBL4298153
|
2023 | Desmoid Tumors |
Gamma-secretase
CHEMBL2094135
|
|
LECANEMAB
CHEMBL3833321
|
2023 | Alzheimer Disease, Dementia |
Amyloid-beta precursor protein
CHEMBL2487
|
|
CILTACABTAGENE AUTOLEUCEL
CHEMBL4802263
|
2022 | Multiple Myeloma |
Tumor necrosis factor receptor...
CHEMBL4523587
|
|
EFLAPEGRASTIM
CHEMBL3833384
|
2022 | Febrile Neutropenia, Neoplasms |
Granulocyte colony-stimulating...
CHEMBL1996
|
|
DEUCRAVACITINIB
CHEMBL4435170
|
2022 | Psoriasis |
Non-receptor tyrosine-protein kinase TYK2
CHEMBL3553
|
|
TAPINAROF
CHEMBL259571
|
2022 | Psoriasis |
Aryl hydrocarbon receptor
CHEMBL3201
|
|
SARS-COV-2 VIRUS, INACTIVATED
CHEMBL6068383
|
2022 | COVID-19, Vaccination | |
|
TAURURSODIOL
CHEMBL272427
|
2022 | — | |
|
DARIDOREXANT
CHEMBL4297590
|
2022 | — |
Orexin receptor
CHEMBL3307226
|
|
CRAVACITINIB
CHEMBL4596392
|
2022 | — | |
|
DARIDOREXANT HYDROCHLORIDE
CHEMBL4650216
|
2022 | Sleep Initiation and Maintenance Disorders |
Orexin receptor type 2
CHEMBL4792
|
|
VIPIVOTIDE TETRAXETAN LUTETIUM
CHEMBL4594730
|
2022 | — | |
|
INDIGOTINDISULFONATE
CHEMBL1091250
|
2022 | — | |
|
TIRZEPATIDE
CHEMBL4297839
|
2022 | Diabetes Mellitus, Diabetes Mellitus, Type 2, Obesity, Overweight |
Gastric inhibitory polypeptide receptor
CHEMBL1784
|
|
TEPLIZUMAB
CHEMBL1743078
|
2022 | Diabetes Mellitus, Type 1 | |
|
SUTIMLIMAB
CHEMBL4297832
|
2022 | Anemia, Hemolytic, Autoimmune, Hemolysis |
Complement C1s subcomponent
CHEMBL3913
|
|
VONOPRAZAN FUMARATE
CHEMBL2064032
|
2022 | — |
Potassium-transporting ATPase
CHEMBL2095173
|
|
SOMATROGON
CHEMBL4297830
|
2022 | Dwarfism, Pituitary |
Growth hormone receptor
CHEMBL1976
|
|
MIRVETUXIMAB SORAVTANSINE
CHEMBL3545132
|
2022 | Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Peritoneal Neoplasms |
Folate receptor alpha
CHEMBL2095182
|
|
DENGUE VIRUS, LIVE ATTENUATED
CHEMBL6068376
|
2022 | Dengue, Vaccination | |
|
VUTRISIRAN SODIUM
CHEMBL5095303
|
2022 | Amyloid Neuropathies, Familial, Polyneuropathies |
Transthyretin mRNA
CHEMBL4296221
|
|
MITAPIVAT
CHEMBL4299940
|
2022 | — |
Pyruvate kinase PKLR
CHEMBL1075126
|
|
LINZAGOLIX CHOLINE
CHEMBL4298171
|
2022 | Leiomyoma |
Gonadotropin-releasing hormone receptor
CHEMBL1855
|
|
TEBENTAFUSP
CHEMBL4297990
|
2022 | Melanoma, Neoplasms, Uveal Neoplasms |
Melanocyte protein PMEL
CHEMBL3712988
|
|
FUTIBATINIB
CHEMBL3701238
|
2022 | Cholangiocarcinoma, Neoplasms |
Fibroblast growth factor receptor
CHEMBL2095217
|
|
MAVACAMTEN
CHEMBL4297517
|
2022 | Cardiomyopathy, Hypertrophic, Cardiovascular Diseases |
Cardiac myosin
CHEMBL3831286
|
|
PHENOBARBITAL
CHEMBL40
|
2022 | Epilepsy | |
|
LENACAPAVIR SODIUM
CHEMBL4802249
|
2022 | HIV Infections, HIV-1 |
Structural capsid protein
CHEMBL2366504
|
|
SPESOLIMAB
CHEMBL4297911
|
2022 | Immune System Diseases, Psoriasis |
IL36 receptor
CHEMBL4665591
|
|
LINZAGOLIX
CHEMBL3668014
|
2022 | — |
Gonadotropin-releasing hormone receptor
CHEMBL1855
|
|
SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE
CHEMBL6068334
|
2022 | Diabetes Mellitus, Type 2 |
Dipeptidyl peptidase 4
CHEMBL284
|
|
RELATLIMAB
CHEMBL3990044
|
2022 | — |
Lymphocyte activation gene 3 protein
CHEMBL4630881
|
|
PHENOBARBITAL SODIUM
CHEMBL149972
|
2022 | Seizures | |
|
EPTACOG BETA (ACTIVATED)
CHEMBL5315078
|
2022 | Hemophilia A, Hemophilia B |
Coagulation factor VII
CHEMBL3991
|
|
XENON XE-129, HYPERPOLARIZED
CHEMBL4594411
|
2022 | Diagnostic Imaging | |
|
FARICIMAB
CHEMBL4297750
|
2022 | Diabetes Complications, Macular Edema, Retinal Neovascularization, Wet Macular Degeneration |
Angiopoietin-2
CHEMBL1783
|
|
VONOPRAZAN
CHEMBL2079130
|
2022 | Gastroesophageal Reflux, Peptic Ulcer | |
|
OTESECONAZOLE
CHEMBL3311228
|
2022 | Candidiasis, Vulvovaginal |
Lanosterol 14-alpha demethylase
CHEMBL4662933
|
|
TERLIPRESSIN
CHEMBL2135460
|
2022 | Hepatorenal Syndrome, Renal Insufficiency |
Vasopressin V1 receptor
CHEMBL1790
|
|
OLUTASIDENIB
CHEMBL4297610
|
2022 | Leukemia, Myeloid, Acute |
Isocitrate dehydrogenase [NADP] cytoplasmic
CHEMBL2007625
|
|
PACRITINIB
CHEMBL2035187
|
2022 | Neoplasms |
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
|
|
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
CHEMBL4594406
|
2022 | Prostatic Neoplasms, Castration-Resistant |
DNA
CHEMBL1892
|
|
GANAXOLONE
CHEMBL1568698
|
2022 | Epilepsy, Epileptic Syndromes, Seizures, Spasms, Infantile |
GABA-A receptor; anion channel
CHEMBL2093872
|
|
INDIGOTINDISULFONATE SODIUM
CHEMBL2105023
|
2022 | — | |
|
VENLAFAXINE BESYLATE
CHEMBL5095051
|
2022 | Anxiety Disorders, Depressive Disorder, Major | |
|
MITAPIVAT SULFATE
CHEMBL4297223
|
2022 | Anemia, Hemolytic, Anemia, Hemolytic, Congenital, Genetic Diseases, Inborn |
Pyruvate kinase PKLR
CHEMBL1075126
|
|
PACRITINIB CITRATE
CHEMBL5095049
|
2022 | Polycythemia Vera, Primary Myelofibrosis |
Activin receptor type-1
CHEMBL1974
|
|
OMIDENEPAG ISOPROPYL
CHEMBL4297666
|
2022 | Glaucoma, Open-Angle, Ocular Hypertension |
Prostaglandin E2 receptor EP2 subtype
CHEMBL1881
|
|
LENACAPAVIR
CHEMBL4594438
|
2022 | Virus Diseases |
Structural capsid protein
CHEMBL2366504
|
Data from ChEMBL 36